{{Rsnum
|rsid=35191146
|geno1=(-;-)
|geno2=(-;G)
|geno3=(G;G)
|Chromosome=6
|Orientation=plus
|Gene=SLC22A1
|position=160139851
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=SLC22A1
}}{{PharmGKB
|RSID=rs35191146
|Name_s=part of SLC22A1:M420del
|Gene_s=SLC22A1
|Feature=Exon/NonSyn
|Evidence=PubMed ID:19940846
|Annotation=Reduced metformin uptake in transfected cells
|Drugs=metformin; MPP+
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111563
}}{{GET Evidence
|gene=SLC22A1
|aa_change=Met420Del
|aa_change_short=M420Del
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs35191146
|overall_frequency_n=12
|overall_frequency_d=128
|overall_frequency=0.09375
|n_genomes=11
|n_genomes_annotated=0
|n_haplomes=11
|n_articles=0
|n_articles_annotated=0
|nblosum100=4
|autoscore=0
|webscore=N
}}
{{PMID Auto
|PMID=23223357
|Title=The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia
}}